2,015 reports of this reaction
2.3% of all ISOTRETINOIN reports
#7 most reported adverse reaction
IRRITABLE BOWEL SYNDROME is the #7 most commonly reported adverse reaction for ISOTRETINOIN, manufactured by JG Pharma Inc.. There are 2,015 FDA adverse event reports linking ISOTRETINOIN to IRRITABLE BOWEL SYNDROME. This represents approximately 2.3% of all 86,016 adverse event reports for this drug.
Patients taking ISOTRETINOIN who experience irritable bowel syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
IRRITABLE BOWEL SYNDROME is a less commonly reported adverse event for ISOTRETINOIN, but still significant enough to appear in the safety profile.
In addition to irritable bowel syndrome, the following adverse reactions have been reported for ISOTRETINOIN:
The following drugs have also been linked to irritable bowel syndrome in FDA adverse event reports:
IRRITABLE BOWEL SYNDROME has been reported as an adverse event in 2,015 FDA reports for ISOTRETINOIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
IRRITABLE BOWEL SYNDROME accounts for approximately 2.3% of all adverse event reports for ISOTRETINOIN, making it a notable side effect.
If you experience irritable bowel syndrome while taking ISOTRETINOIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.